Glycolipid metabolism disorder are major threats to human health and life. Genetic,
environmental, psychological, cellular, and molecular factors contribute to their …

Metabolic diseases including type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver
disease (NAFLD), and metabolic syndrome (MetS) are alarming health burdens around the …

Mass spectrometry (MS)-based omics technologies are now widely used to profile small
molecules in multiple matrices to confer comprehensive snapshots of cellular metabolic …

As a consequence of a sedentary lifestyle as well as changed nutritional behavior, today's
societies are challenged by the rapid propagation of metabolic disorders. A common feature …

Simple Summary Glycolipid metabolic disorders (GLMDs) result from imbalances in
glycolipid levels, leading to various health issues, including obesity, diabetes, liver …

The application of lipidomics, after genomics, proteomics and metabolomics, offered largely
opportunities to illuminate the entire spectrum of lipidome based on a quantitative or semi …

The human gastrointestinal tract colonizes a large number of microbial microflora, forms a
host-microbiota co-metabolism structure with the host to participate in various metabolic …

Type 2 diabetes mellitus (T2DM) is a burdensome global disease. In-depth understanding of
its mechanism will help to optimize diagnosis and treatment, which reduces the burden …

Metabolic disorders are increasingly prevalent worldwide, leading to high rates of morbidity
and mortality. The variety of metabolic illnesses can be addressed through personalized …

Type 2 diabetes mellitus (T2DM) is one of the most common diseases of endocrine and
metabolic disorders, whose mechanism is still largely unknown. Fortunately, various “omics” …